US turns down Brazil carbendazim deal
The US Food and Drug Administration (FDA) has turned down a request from the Brazilian Citrus Exporters Association (BCEA) for discretion in its residue monitoring for the fungicide, carbendazim, in imported orange juice. The BCEA wanted the FDA to base its determinations on diluted “single strength” juice rather than the concentrated juice being imported from Brazil. It called for such an approach to be taken until June 2013. The association’s members committed to stop using carbendazim by the end of last month, but it would take 18 months for shipments to be free of residues, they argued. The FDA began seizing shipments of imported orange juice last month because of the presence of illegal carbendazim residues ( Agrow No 631, p 13).